UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No.____________)*
Derma Sciences, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
249827106
- --------------------------------------------------------------------------------
(CUSIP Number)
Raymond C. Hedger
Hedger & Hedger
1800 Linglestown Road, Suite 206, Harrisburg, PA 17110
(717)238-1800
- --------------------------------------------------------------------------------
(Name,Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 23, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
<PAGE>
PAGE 2
CUSIP No. 249827106 Schedule 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mary G. Clark ###-##-####
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 775,474
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 775,474
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
775,474
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
16.98%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
PAGE 3
CUSIP No. 249827106 Schedule 13D
Item 1. Security and Issuer
This Schedule 13D relates to the common stock, $.01 par value (the
"Common Stock"), of Derma Sciences, Inc., a Pennsylvania corporation (the
"Issuer"), whose principal executive offices are located at 214 Carnegie Center,
Suite 100, Princeton, New Jersey 18518.
The principal executive officers of the Issuer, all of whom may be
reached at the Issuer's principal executive offices, are set forth below:
Name Position(s)
Edward J. Quilty Chairman of the Board
Richard S. Mink Chief Operating Officer
Charles F. Caudell, III Executive Vice President for Field Operations
Stephen T. Wills, CPS, MST Vice President and Chief Financial Officer
Item 2. Identity and Background
This Schedule 13D is being filed by Mary G. Clark (the "Reporting
Person"). Certain information with respect to the Reporting Person is set forth
below:
Name and Address Mary G. Clark
201 Joleona Drive
Clarks Summit, PA 18940
Principal Occupation: Founder and Director of Issuer;
Special Consultant for Scientific Affairs to Issuer
Criminal convictions: None
Civil proceedings: None
Citizenship: United States
<PAGE>
PAGE 4
CUSIP No. 249827106 Schedule 13D
Item 3. Source and Amount of Funds or Other Consideration
Not Applicable.
Item 4. Purposes of the Transactions
Not Applicable.
Item 5. Interest in Securities of the Issuer
See cover page, items 7, 9 and 11. The Reporting Person maintains both
voting power and dispositive power relative to all such shares.
On January 23, 1998 the Reporting Person sold, in a transaction not
involving a public offering, 250,000 shares of common stock of the Issuer, at
$1.00 per share, to three institutional investors. The Issuer has agreed to
register for public resale the shares transferred in this transaction.
Item 6. Contracts, Arrangements, Understandings or Relationships with respect
to Securities of the Issuer
None.
Item 7. Material to Be Filed as Exhibits
1. Limited power of attorney
Signatures
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
/s/ Mary G. Clark*
----------------------
By: Raymond C. Hedger, Jr.
Attorney-in-Fact
February 2, 1998
* Signed by Raymond C. Hedger, Jr. as attorney-in-fact pursuant to Limited
Power of Attorney dated January 23, 1998 and filed as Exhibit 1.
<PAGE>
EXHIBIT 1
LIMITED POWER OF ATTORNEY
I, THE UNDERSIGNED MARY G. CLARK, hereby authorize and appoint Raymond
C. Hedger, Jr., Hedger & Hedger, Harrisburg, Pennsylvania, as my
attorney-in-fact for me and on my behalf to file such Schedules 13D, and
amendments thereto, with the United States Securities and Exchange Commission
and National Securities Exchanges as may be required under the Securities
Exchange Act of 1934, Regulations thereunder and the Rules of said Exchanges.
IN WITNESS WHEREOF, I have hereunder placed my hand this 23rd day of
January, 1998.
/s/ Mary G. Clark
---------------------------
